Developing MRI Technologies for Atrial Fibrillation

Enrolling by invitation

Conditions studied: Atrial Fibrillation (AF)

In brief

To measure image quality of damaged areas of the heart in patients with Atrial fibrillation using the contrast Gadopiclenol vs conventional Gadolinium-based contrast agents(GBCA)

Key facts

Study ID

NCT07083115

Run by

The Cleveland Clinic

People needed

50

Starts

2025-01-16

Expected to finish

2028-09-01

Last updated by the study team

2026-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Atrial Fibrillation

You may not qualify if…

• Contraindications to MRI
• Contraindications to Gadolinium based contrast agents.

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.